03 October 2026, Georgia: A Minneapolis food-technology company has begun harvesting the first outdoor, commercial-scale planting of peanuts gene-edited to remove three of the proteins most responsible for severe peanut allergy reactions, according to the company and trade-press coverage published in August 2026, a milestone its backers say moves the long-studied idea of a lower-allergen peanut from the greenhouse to the field for the first time.
The crop was planted in Georgia in spring 2026 by Nurtured Nuts Co., a startup founded by Bryant Williams, using gene-edited peanut lines supplied by AgriNetica, the United States arm of the Israeli agricultural biotechnology company BetterSeeds. The companies used CRISPR, a gene-editing tool that lets researchers disable or alter specific genes without necessarily introducing DNA from another species, to knock out the genes that produce three proteins called Ara h 2, Ara h 6 and Ara h 7. Those three proteins are among the handful of peanut allergens most strongly linked to severe, potentially life-threatening allergic reactions in sensitized people, and reducing or removing them is a strategy researchers have pursued in laboratory settings for more than a decade. What is new here is the scale: this is being described by the companies as the first time such edited peanuts have been grown outdoors at commercial field scale in the United States, rather than in a greenhouse or small research plot.
Harvest of the Georgia crop was expected in September 2026, with processing into usable peanut products planned for October. Nurtured Nuts has said it intends to raise additional funding this year to support that processing step and scale toward a commercial product. The company has set 2027 as its target for the product reaching the market, though that timeline depends on regulatory review.
That regulatory review is the key qualifier on this story. Nurtured Nuts says it has made what it calls significant progress in discussions with the US Food and Drug Administration, but the company itself describes the process as still in an early, scientific-credibility-building phase, and no allergen-reduction claims have yet been approved or independently published with specific percentage figures for how much the edited peanuts’ allergen load has actually fallen. The company has not yet released peer-reviewed or third-party-verified biochemical data quantifying the reduction in the three target proteins; that data, if and when published, would be the figure to watch for before drawing firm conclusions about how much allergen risk the crop actually removes.
It is also worth being precise about what the product is being designed to do. The companies have framed the goal primarily around reducing the risk of severe reactions from accidental cross-contact or trace exposure, the scenario that causes most peanut-allergy emergencies, rather than necessarily making the peanuts safe for allergic individuals to eat deliberately. More than 6 million Americans are estimated to have a peanut allergy, and accidental exposure in shared kitchens, school cafeterias and processed foods is a persistent source of medical emergencies and product recalls across the food industry.
What the gene editing actually changes
Peanuts naturally contain more than a dozen distinct allergenic proteins, and conventional breeding has struggled to remove the most problematic ones because they are often linked to other traits like seed storage or germination. CRISPR allows a more targeted approach, disabling the specific genes that encode Ara h 2, Ara h 6 and Ara h 7 while, in principle, leaving the rest of the plant’s genetics intact. Because the technique edits the peanut’s own genes rather than inserting foreign DNA, products developed this way may in some jurisdictions face a lighter regulatory path than older-style genetically modified crops, though US rules and agency practice in this area continue to evolve and final classification will depend on FDA’s review of this specific product.
The approach drew attention at the Institute of Food Technologists’ annual IFT FIRST innovation competition in July 2026, where Nurtured Nuts won the event’s grand prize, a signal of interest from the broader food industry even as the underlying science remains unpublished in detail.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
